Asthma can be unpredictable, turning everyday activities into challenges when symptoms flare up. Managing asthma at home requires a proactive approach to minimize triggers and maintain a healthy ...

May is asthma awareness month, and researchers want to raise awareness about the need to get newer, more effective therapies into the hands of patients. Some 25 million Americans have asthma, and more ...

Asthma inhalers can be for quick relief or long-term control. Rescue inhalers work by relaxing your airway muscles to help ...

Asthma is a complex lung disease that results from many different genetic and environmental risk factors. No single strategy can prevent asthma, but you can take steps to help reduce your baby’s risk ...

(BPT) – If you or a family member experiences allergies or asthma, you know how challenging it is to avoid triggers. When pollen is high, its effects show up immediately through irritation of your ...

Tezepelumab may allow patients with severe, uncontrolled asthma who are oral corticosteroid-dependent to decrease their OCS use.

New research has found that drinking camel milk can reduce the severity of asthma caused by house dust mites, a major trigger. While the research is still in the early stages, it opens the door to ...

Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Asthma is a widespread respiratory condition affecting approximately 5.4 million people in the UK, and 1.1 million are children. 1,2 Asthma is the most widespread long-term condition among young ...

Asthma is a chronic respiratory condition that affects millions of people worldwide. It involves inflammation and narrowing of the airways, making it difficult to breathe. While genetic factors play a ...

Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...